Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ?? PTSC, would gain a higher ownership %

Hugely important point in terms of future revenue for PTSC.

Yes, I recall that TPL & PTSC agreed that a default in loan repayment resulted in diluted percentage from 50/50. Again, we await the detail of what exactly the current situation is and confirmation of what future percentage split will be.

Very exciting times.

Good Luck To All

Share
New Message
Please login to post a reply